The College of American Pathologists (CAP) released its newest evidence-based practice guideline, "Human Papillomavirus (HPV) Testing in Head and Neck Carcinomas," on December 19, 2017.
The guideline, which recommends accurate assessment of a patient's high-risk HPV status, directly or by surrogate markers, was developed by an interdisciplinary, expert panel that included pathologists, surgeons, radiation oncologists, medical oncologists, patients, and patient advocates.
Based on a screening of 2,200 peer-reviewed articles and a review of evidence from 492 studies, the panel issued 14 final recommendations in the guideline.
Learn more on the CAP website.
Posted 1/3/2018
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
